Background

InnoScience (Suzhou) Technology Holding Co., Ltd. (ticker: INNOSCIENCE SUZHOU TECHNOL-H) is a Hong Kong‑listed semiconductor company that develops and sells gallium nitride (GaN) power‑semiconductor products. The company’s product portfolio includes GaN wafers, discrete chips, integrated circuits, and modules for consumer electronics, renewable energy, industrial, automotive, and data‑center applications. As of 5 July 2026, the stock closed at HKD 56.8, with a market capitalization of approximately HKD 55.5 billion. The company was founded in 2015 and is headquartered in Suzhou, China.

Key Event: US ITC Final Determination

On 7 May 2026 the U.S. International Trade Commission (US ITC) issued a Final Determination that InnoScience infringed an Infineon Technologies AG patent covering GaN technology. After the completion of the 60‑day Presidential Review Period on 7 July 2026, the determination was confirmed. As a result:

  • Import of InnoScience’s patent‑infringing GaN products into the United States is prohibited.
  • Sale of those products within the United States is likewise banned.
  • The decision applies to all GaN‑based chips, wafers, and modules that fall under the scope of the disputed patent.

The ban is specific to the U.S. market and does not alter InnoScience’s status in other jurisdictions. The determination was reported by multiple news outlets, including Finanznachrichten.de, PRNewswire, NewsWire.ca, Presseportal.de, and Finanzen.net.

Implications for InnoScience

  1. Revenue Impact The U.S. market is a significant customer base for GaN power devices. Loss of access to this market may reduce sales volume, particularly for high‑margin automotive and industrial segments that rely on U.S. demand.

  2. Supply Chain Adjustments InnoScience will need to re‑route production and distribution to alternative markets. This may involve increasing capacity in China, Southeast Asia, or Europe to compensate for the loss of U.S. orders.

  3. Legal and Compliance Costs The company will likely incur legal fees related to the dispute and potential counter‑claims. Ongoing monitoring of the ITC decision and compliance with U.S. import regulations will require dedicated resources.

  4. Investor Sentiment The ban may negatively affect investor confidence, reflected in short‑term volatility around the stock price. The company’s market cap of HKD 55.5 billion underscores the importance of maintaining a diversified customer base.

Strategic Responses

  • Product Differentiation Emphasize proprietary technologies or alternative patent portfolios to mitigate reliance on the disputed IP.

  • Market Diversification Accelerate penetration in European and Asian markets where regulatory barriers are lower and demand for GaN devices is growing.

  • Collaborations and Licensing Explore licensing agreements or joint ventures with non‑U.S. partners to maintain revenue streams and share intellectual property risks.

  • Regulatory Engagement Engage with trade authorities and industry bodies to monitor any changes in U.S. trade policy that could affect future market access.

Conclusion

The US ITC’s confirmation of the ban on InnoScience’s GaN products constitutes a significant regulatory challenge for the company. While the immediate impact is limited to the U.S. market, the broader implications for revenue, supply chain, and investor perception are substantial. InnoScience must implement strategic measures to diversify its market presence, manage legal exposure, and maintain competitiveness in the rapidly evolving GaN semiconductor industry.